- О нас
- Портфель разработок
- Клинические исследования
- Hовости & Список изданий
- Развитие бизнеса
We seek to support the development of novel cancer therapies by providing venture capital and / or scientific development expertise, which would strengthen our portfolio of companies.
We invest in biotech companies with highly innovative technologies and oncology product candidates at stages ranging from preclinical to clinical proof of concept. We review investment opportunities on a global basis with a prime focus on European companies.
Typically, we invest jointly with other investors, gaining minority ownership with the option to make further investments over several years to maximize the return. Our investment fund’s structure does not have a finite life.
We apply a state of the art scouting and evaluation process to identify attractive investment opportunities. We pledge to perform a thorough evaluation of opportunities by our internal experts with the help of external advisors.
For an overview of PPF Biotech Portfolio please see section Affliated Companies & Partners.